NovaBridge Biosciences (NBP) — Stock Score Summary

NovaBridge Biosciences (NBP) has a MoatMap StockRank of 8/100 based on Quality (39/100), Value (43/100), and Momentum (7/100) factor scores. The current signal is STRONG SELL. NovaBridge Biosciences is an early-stage healthcare company with insufficient data, low quality metrics, and no clear competitive advantage.

NovaBridge Biosciences is a biotechnology company focused on the discovery and development of novel therapeutic candidates, likely targeting specific diseases with unmet medical needs. The company's competitive position hinges on the innovation of its drug pipeline and the potential for its proprietary compounds to address significant medical challenges.

Key Financial Metrics

Price$1.59
Market Cap$216M
P/E (Forward)-1.70
Price/Book0.90
Return on Equity-40.9%
Return on Invested Capital-40.4%
Debt/Equity1.33
Gross Margin0.0%
Operating Margin0.0%
Free Cash Flow$-37M

NovaBridge Biosciences operates in the Biotechnology industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is NovaBridge Biosciences’s (NBP) StockRank?
MoatMap’s StockRank for NovaBridge Biosciences (NBP) is 8/100, with a Strong Sell signal. It is a composite of Quality (39), Value (43), and Momentum (7) factor ranks across MoatMap’s 19,000+ stock universe.
Does NovaBridge Biosciences have an economic moat?
NovaBridge Biosciences (NBP) has a Quality factor score of 39/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is NovaBridge Biosciences a buy, hold, or sell?
MoatMap’s current signal for NovaBridge Biosciences (NBP) is Strong Sell, based on a StockRank of 8/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is NovaBridge Biosciences in?
NovaBridge Biosciences (NBP) operates in the Healthcare sector, specifically the Biotechnology industry (United States).
Browse all ranked stocksNBP deep dive reportAI ChampionsHow we score stocksSense-check another stock